Results 51 to 60 of about 8,310 (238)

Stock Price Deviations From Fundamentals Levels: Mis‐Valuation due to Investor Overconfidence?

International Journal of Finance &Economics, EarlyView.
ABSTRACT We use the Residual Income Valuation Model to obtain fundamental values for sample stocks in six Eurozone markets. We then estimate the deviation between the fundamental values and actual stock prices. Subsequently, we examine whether these deviations can be systematically explained by business cycle trends, trends in local economic sentiment,
Stella N. Spilioti, Andrianos E. Tsekrekos   +1 more
wiley   +1 more source

Comparison of two assessments of real‐world data and real‐world evidence for regulatory decision‐making

Clinical and Translational Science
Real‐world data (RWD) and real‐world evidence (RWE) are increasingly used to support regulatory decision making, but regulatory agencies and stakeholders may apply different definitions for RWD and use different criteria to determine when analysis of ...
Lily Yuan, Motiur Rahman, John Concato
doaj   +1 more source

Reduced length of stay and improved perioperative outcomes in robotic‐arm‐assisted TKA: A real‐world evidence study of 63,931 cases from German hospitals

Knee Surgery, Sports Traumatology, Arthroscopy, EarlyView.
Abstract Purpose Robotic‐arm‐assisted surgery is increasingly used in orthopaedics due to its potential clinical benefits. This real‐world data analysis evaluated the impact of image‐based, robotic‐arm‐assisted total knee arthroplasty (raTKA) over non‐robotic‐arm‐assisted total knee arthroplasty (nraTKA) on perioperative outcomes in Germany based on a ...
Lars‐Rene Tuecking, Marco Ezechieli, Christoph Barkhausen, Christian Hendrich, Lea Charlotte Wienholt, Christoph Pross, Rüdiger von Eisenhart‐Rothe, Henning Windhagen   +7 more
wiley   +1 more source

Fundamental analysis of RWE AG title

, 2008
Cílem diplomové práce "Fundamentální analýza akciového titulu RWE AG" je stanovení vnitřní hodnoty akcie RWE AG na základě hĺbkové analýzy. První -- teoretická -- čásť pojednáva o finančním prostředí, ve kterém se daný titul obchoduje a kótuje ...
Nemšáková, Alena
core   +1 more source

National Policy Coherence Counts for Reducing Inequality in Global Climate and Development Agendas

Sustainable Development, EarlyView.
ABSTRACT International institutions promote policy coherence as crucial to the effective and fair implementation of global sustainability agendas, though the evidence for its benefits is slim. We present here the first systematic cross‐country dataset on the consequences of national government efforts to promote policy coherence for vulnerable groups ...
Katherine Browne, Adis Dzebo, Zoha Shawoo, Mario Cardenas, Pierrick Chalaye, Alexia Faus Onbargi, Cassilde Muhoza, Patricia Nicdao, Nokwethaba Makhanya, Navam Niles, Priyatma Singh   +10 more
wiley   +1 more source

RWE Geschaeftsbericht 1988/89

, 1990
SIGLEAvailable from Rheinisch-Westfaelisches Elektrizitaetswerk A.G.
Rheinisch-Westfaelisches Elektrizitaetswerk A.G. (RWE), Essen (Germany)
core  

Umwelttarif der RWE. Monitoring Bericht 2002

, 2008
Seit 1996 begleitet das Fraunhofer-Institut für Solare Energiesysteme ISE den Umwelttarif der RWE. Mit dem vorliegenden Bericht informieren wir Sie abschließend über die Messergebnisse und Betriebserfahrungen mit den Anlagen des Umwelttarifs.

core   +1 more source

Palbociclib in the Treatment of HR+/ HER2‐ Advanced or Metastatic Breast Cancer in Australia: A Real‐World Retrospective Analysis

Asia-Pacific Journal of Clinical Oncology, EarlyView.
This study investigated the real‐world use of CDK4/6 inhibitors in Australian patients with HR+/HER2‐ advanced or metastatic breast cancer, providing data on patient demographics, treatment patterns, and outcomes with palbociclib. ABSTRACT Background There is limited real‐world data on the use of CDK4/6 inhibitors in Australian patients with HR+/HER2 ...
Louise Nott, Eugene Moylan, Maree Colosimo, Giles Stratton, Thomas Chiu, Mahsa H. Kouhkamari, Maureen Hitschfeld, Jessica Michie, Richard De Boer   +8 more
wiley   +1 more source

Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

BMJ Open
Objective The Canadian Real-world Evidence for Value in Cancer (CanREValue) Collaboration was established in response to growing interest in using real-world evidence (RWE) to support health technology assessment (HTA).
Stuart Peacock, Avram Denburg, Petros Pechlivanoglou, Wanrudee Isaranuwatchai, Claire de Oliveira, Yvonne Bombard, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Carole Chambers, Maureen Trudeau, Craig C Earle, Kelvin Kar-Wing Chan, Winson Y Cheung, Pam Takhar, William K Evans, Caroline Muñoz, Erica Craig, Marc Geirnaert, Tarry Ahuja, Riaz Alvi   +23 more
doaj   +1 more source

Creating and using real-world evidence to answer questions about clinical effectiveness

Journal of Innovation in Health Informatics, 2015
New forms of evidence are needed to complement evidence generated from randomised controlled trials (RCTs). Real-World Evidence (RWE) is a potential new form of evidence, but remains undefined.This paper sets to fill that gap by defining RWE as the ...
Simon de Lusignan, Laura Crawford, Neil Munro   +2 more
doaj   +1 more source